The Development
Avela Health, a Carson, California-based startup specializing in virtual autism diagnostics and support services, has announced a significant funding round, securing $6.45 million. Public documents indicate the company is targeting a total raise of $6.9 million, with the initial offering closing on December 17, 2025, attracting 15 investors. Founded in 2024, Avela Health is led by co-founders Robin McIntosh as CEO and Katherine Monti as President and Chief Operating Officer. Cynthia Anderson serves as the clinical co-founder and Chief Clinical Officer, bringing a strong clinical foundation to the company’s offerings.
The company’s service portfolio is comprehensive, addressing various needs across the autism spectrum. It provides virtual autism diagnostic services for children, teenagers, and adults, aiming to streamline access to crucial initial assessments. Beyond diagnostics, Avela Health offers virtual applied behavior analysis (ABA) therapy, support groups, and individualized treatment planning. Notably, it also provides Acceptance and Commitment Therapy (ACT) specifically tailored for autistic adults, reflecting a broader approach to behavioral health support.
The leadership team brings prior experience from the virtual health sector; both McIntosh and Monti previously held executive positions at Workit Health, a virtual addiction treatment provider. McIntosh served as CEO and co-founder, while Monti progressed to Chief Operating Officer. This background in scaling virtual healthcare solutions is likely a key factor in Avela Health’s strategy and investor confidence.
Market Impact
Avela Health’s successful funding round underscores the growing investor interest in virtual autism therapy, a segment poised to address significant access barriers in traditional care models. The virtual care landscape for autism services is rapidly evolving, with several startups leveraging telehealth to connect individuals with much-needed support. This approach is particularly critical in regions where geographical limitations, long waitlists, or a shortage of qualified professionals hinder access to in-person services.
However, the market is not without its challenges and competitive pressures. While companies like As You Are have navigated corporate restructuring to expand diagnostic services across 48 states, and AnswersNow recently secured $40 million to scale its BCBA-led virtual care model, the sector has also seen failures. Meliora Health, for instance, ceased operations in April 2025, highlighting the complexities of sustaining and expanding virtual services, particularly those with international ambitions. Forta Health has also made strides, making its virtual ABA services available in nearly all states, indicating a robust and competitive environment.
The broader autism therapy industry continues to evaluate the optimal integration of telehealth services. While some view virtual care as a standalone solution, others see it as a valuable complement to traditional in-person models. A major executive in the behavioral health sector has publicly expressed expectations for telehealth to assume a significantly larger role in the future, suggesting that Avela Health’s investment aligns with a prevailing industry trend towards digital transformation and expanded accessibility.
What’s Next
Avela Health is actively expanding its partnerships with health plans to broaden service coverage. Currently, its virtual diagnostic services are covered by several BlueCross BlueShield entities in New Jersey and North Carolina. These diagnostic services are available in 45 states, with a cash-pay option priced at $2,000. For therapy services, Avela Health currently offers in-network coverage exclusively in New Jersey, with a cash-pay option available at $1,700 per month. The recent funding is expected to accelerate Avela Health’s efforts to secure additional in-network agreements and expand its therapy services into more states, thereby increasing access for a wider population.
The company’s strategic focus on both diagnostics and ongoing therapy, combined with its emphasis on working with health plans, positions it to become a significant player in the virtual autism care space. The capital infusion will likely be directed towards technology development, expanding its network of qualified clinicians, and navigating the complex landscape of state-specific regulations and insurance reimbursement policies. As the industry continues to define the role of telehealth, Avela Health’s growth trajectory will offer valuable insights into the viability and scalability of virtual-first models in applied behavior analysis and broader autism support.
Fast Facts
| Key Point | Why It Matters for ABA |
|---|---|
| $6.45M raised, targeting $6.9M | Significant capital for virtual ABA expansion and market competition. |
| Virtual diagnostics in 45 states | Addresses critical access barriers for initial autism assessments nationwide. |
| Virtual ABA and ACT for adults | Expands therapeutic options beyond traditional child-focused ABA, including adult support. |
| In-network therapy in New Jersey only | Highlights ongoing challenges and strategic focus needed for broader insurance coverage. |
| Founded in 2024 | Indicates rapid growth and investor confidence in a relatively new market entrant. |
Expert Perspective
The successful funding round for Avela Health underscores the increasing demand and investor confidence in virtual solutions for autism therapy, signaling a continued shift towards accessible digital care models.
Source: bhbusiness.com
